Bio-protein Drug Market, Global Outlook and Forecast 2023-2028

Report ID: 1139190 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story

This report contains market size and forecasts of Bio-protein Drug in global, including the following market information:
Global Bio-protein Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Bio-protein Drug Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Bio-protein Drug companies in 2021 (%)
The global Bio-protein Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monoclonal Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bio-protein Drug include Abbott Laboratories, Bayer AG, Eli Lilly and Company, Amgen Inc., Biocon Ltd., Dr. Reddy’s Laboratories, Roche, Fresenius kabi and GlaxoSmithKline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bio-protein Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bio-protein Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bio-protein Drug Market Segment Percentages, by Type, 2021 (%)
Monoclonal Antibodies
Therapeutic Proteins
Vaccines
Global Bio-protein Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bio-protein Drug Market Segment Percentages, by Application, 2021 (%)
Pharma and Biotech Companies
CROs
Academics
Global Bio-protein Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bio-protein Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bio-protein Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Bio-protein Drug revenues share in global market, 2021 (%)
Key companies Bio-protein Drug sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Bio-protein Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Bayer AG
Eli Lilly and Company
Amgen Inc.
Biocon Ltd.
Dr. Reddy’s Laboratories
Roche
Fresenius kabi
GlaxoSmithKline
Johnson & Johnson
Merck
Novartis AG
Panacea Biotec
ProBioGen AG
Sanofi
Reliance Life Science Pvt. Ltd.

Frequently Asked Questions
Bio-protein Drug Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Bio-protein Drug Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Bio-protein Drug Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports